Harry S. Truman Memorial Veterans Hospital, Department of Neurology, University of Missouri-School of Medicine, Columbia, MO, USA.
Harry S. Truman Memorial Veterans Hospital, Department of Neurology, University of Missouri-School of Medicine, Columbia, MO, USA.
Neuropharmacology. 2020 Dec 1;180:108332. doi: 10.1016/j.neuropharm.2020.108332. Epub 2020 Sep 19.
Alcohol use disorder (AUD) develops after chronic and heavy use of alcohol. Insomnia, a hallmark of AUD, plays a crucial role in the development of AUD. However, the causal mechanisms are unknown. Since chronic alcohol reduces acetylated histones and disrupts the epigenome, we hypothesized that chronic alcohol exposure will reduce acetylated histones in wake-promoting regions of the brain to cause insomnia during alcohol withdrawal.
Adult male C57BL/6J mice, surgically instrumented for electrophysiological monitoring of sleep-wakefulness, were exposed to chronic alcohol (6.8%) consumption using Lieber-DeCarli liquid diet. Three experiments were performed. First, the effect of chronic alcohol consumption was examined on sleep-wakefulness during 7 days of withdrawal. Second, the expression of acetylated histones, H3 lysine 14 (AcH3K14), was examined in two major sleep-wake regulatory brain regions: basal forebrain (BF) and lateral hypothalamus (LH) of the brain by using western blotting. Next, blockade of histone deacetylase, via systemic administration of TSA was examined on alcohol-induced changes in sleep-wakefulness.
Alcoholic mice displayed a significant reduction in the quality and quantity of NREM sleep coupled with a significant increase in wakefulness that lasted for several days during alcohol withdrawal. In addition, alcoholic mice displayed a significant reduction in the expression of AcH3K14 in both BF and LH. Systemic administration of TSA significantly attenuated insomnia and improved the quality and quantity of sleep during alcohol withdrawal.
Based on our results, we suggest that a causal relationship exists between reduced histone acetylation and insomnia during alcohol withdrawal.
酒精使用障碍(AUD)是在长期和大量饮酒后发展起来的。失眠是 AUD 的一个标志,在 AUD 的发展中起着至关重要的作用。然而,因果机制尚不清楚。由于慢性酒精会降低乙酰化组蛋白并破坏表观基因组,我们假设慢性酒精暴露会减少大脑中促进觉醒区域的乙酰化组蛋白,从而在酒精戒断期间导致失眠。
成年雄性 C57BL/6J 小鼠,通过手术植入用于睡眠-觉醒电生理监测的仪器,使用 Lieber-DeCarli 液体饮食进行慢性酒精(6.8%)消耗。进行了三项实验。首先,检查慢性酒精消耗对戒断 7 天期间睡眠-觉醒的影响。其次,通过 Western 印迹法检查两种主要的睡眠-觉醒调节脑区:基底前脑(BF)和下丘脑外侧(LH)中乙酰化组蛋白 H3 赖氨酸 14(AcH3K14)的表达。接下来,通过系统给予 TSA 检查组蛋白去乙酰化酶的阻断对酒精引起的睡眠-觉醒变化的影响。
酒精小鼠在酒精戒断期间表现出 NREM 睡眠质量和数量显著减少,同时清醒时间显著增加,持续数天。此外,酒精小鼠在 BF 和 LH 中的 AcH3K14 表达均显著降低。系统给予 TSA 可显著减轻失眠并改善酒精戒断期间的睡眠质量和数量。
根据我们的结果,我们认为在酒精戒断期间,组蛋白乙酰化减少与失眠之间存在因果关系。